
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Mycobacterium immunogen
Introduction
Overview
Overview
Mycobacterium immunogenum is a species of the phylum actinobacteria (Gram-positive bacteria with high guanine and cytosine content, one of the dominant phyla of all bacteria), belonging to the genus mycobacterium.
These non-tuberculous mycobacteria are sometimes found in fouling water-based cutting fluids, often causing hypersensitivity pneumonitis to the machinists in the affected grinding plants.[2]
Treatment
Treatment
Antimicrobial regimen
- M. immunogenum isolates [3]
- susceptible: Amikacin AND Clarithromycin but
- resistant: Ciprofloxacin, Doxycycline, Cefoxitin, Tobramycin, and Sulfamethoxazole
- NOTE: The optimal therapy for this organism is unknown; however, successful therapy is likely difficult due to the extensive antibiotic resistance of the organism
References
References
- β Wilson, RW; Steingrube, VA; BΓΆttger, EC; Springer, B; Brown-Elliott, BA; Vincent, V; Jost Jr, KC; Zhang, Y; et al. (2001). “Mycobacterium immunogenum sp. Nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy”. International journal of systematic and evolutionary microbiology. 51 (Pt 5): 1751β64. doi:10.1099/00207713-51-5-1751. PMIDΒ 11594606.
- β Wallace, R. J.; Zhang, Y.; Wilson, R. W.; Mann, L.; Rossmoore, H. (2002). “Presence of a Single Genotype of the Newly Described Species Mycobacterium immunogenum in Industrial Metalworking Fluids Associated with Hypersensitivity Pneumonitis”. Applied and Environmental Microbiology. 68 (11): 5580β4. doi:10.1128/AEM.68.11.5580-5584.2002. PMCΒ 129929. PMIDΒ 12406752.
- β Griffith, David E.; Aksamit, Timothy; Brown-Elliott, Barbara A.; Catanzaro, Antonino; Daley, Charles; Gordin, Fred; Holland, Steven M.; Horsburgh, Robert; Huitt, Gwen; Iademarco, Michael F.; Iseman, Michael; Olivier, Kenneth; Ruoss, Stephen; von Reyn, C. Fordham; Wallace, Richard J.; Winthrop, Kevin; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America (2007-02-15). “An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases”. American Journal of Respiratory and Critical Care Medicine. 175 (4): 367β416. doi:10.1164/rccm.200604-571ST. ISSNΒ 1073-449X. PMIDΒ 17277290.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
